BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  American Society of Mass Spectrometry in Indy

  From June 4-8, the city of Indianapolis had the privilege of playing host to nearly 6500 scientists from around the world who gathered to discuss all aspects of using mass spectrometry in a wide variety of applications.

  December 22, 2017

   · 

  1 min read
• Policy

  QIAGEN to Take Impairment on Deferred Tax Assets, Informs on Expected Impacts of New U.S. Tax Law and Other Changes in Global Tax Environment

  QIAGEN N.V.announces that, mainly as a consequence of the new U.S. tax legislation, it will take an after-tax charge on net income of approximately $110-120 million (or about $0.47-$0.52 per share) in the fourth quarter of 2017.

  December 22, 2017

   · 

  1 min read
• Genetown

  Bioverativ Announces 2018 Annual Meeting of Stockholders

  Bioverativ announced today that its 2018 Annual Meeting of Stockholders has been scheduled for April 25, 2018.

  December 22, 2017

   · 

  1 min read
• 

  Policy

  SEC Subpoenas Massachusetts’ Ocular Therapeutix Over Pain Relief Implant

  The Company denies any allegations of wrongdoing and intends to vigorously defend against these lawsuits.

  December 22, 2017

   · 

  7 min read
• Business

  Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer

  Board of Director Mario Stifano resigned his position effective December 12, 2017, due to conflicting time priorities.

  December 22, 2017

   · 

  2 min read
• 

  BioMidwest

  Zimmer Biomet Shows Off Pilot Data for nStride Knee Injection

  The pilot study enrolled 46 patients with unilateral, mild-to-moderate, symptomatic knee OA pain from the four trial sites across Europe.

  December 22, 2017

   · 

  7 min read
• Viemed Commences Trading on the TSXV

  The common shares of Viemed (the “Viemed Shares”) will commence trading on the TSX Venture Exchange (the “TSXV”) on December 22, 2017 under the stock symbol “VMD”.

  December 22, 2017

   · 

  8 min read
• Biotech Bay

  Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  Fluidigm today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent directors, granted an equity award on December 15, 2017.

  December 22, 2017

   · 

  2 min read
• BioMidwest

  DiaMedica Therapeutics Announces Results of Annual General and Special Meeting of Shareholders

  DiaMedica today announced that at its Annual General and Special Meeting of shareholders held on December 21, 2017.

  December 22, 2017

   · 

  2 min read
• Avivagen Announces the Granting of Options

  The options, which shall be vested over an eight-quarter period, are exercisable up to five years from the issuing date, and have a strike price of $0.90.

  December 22, 2017

   · 

  3 min read